Benzyl piperidine compounds as lysophosphatidic acid (LPA) receptor antagonist

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9527850
APP PUB NO 20150011557A1
SERIAL NO

14344267

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides novel substituted benzyl piperidine compounds according to Formula (I) as lysophosphatidic acid (LPA) receptor antagonists, their manufacture and use for the treatment of proliferative or inflammatory diseases, such as cancer, fibrosis or arthritis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK PATENT GMBH64293 DARMSTADT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burger, Christa Darmstadt, DE 19 315
Busch, Michael Darmstadt, DE 33 395
Poeschke, Oliver Wiesbaden, DE 10 24
Schiemann, Kai Seeheim-Jugenheim, DE 73 870
Staehle, Wolfgang Ingelheim, DE 46 554
Wienke, Dirk Darmstadt, DE 10 103

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 27, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00